BMCM
LLY icon

Bryn Mawr Capital Management’s Eli Lilly LLY Stock Holding History

Bryn Mawr Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16M Sell
3,434
-1,049
-23% -$1.06M 0.15% 120
2025
Q4 		$4.82M Sell
4,483
-526
-11% -$503K 0.23% 96
2025
Q3 		$3.82M Sell
5,009
-224
-4% -$167K 0.19% 108
2025
Q2 		$4.08M Buy
5,233
+52
+1% +$40.4K 0.22% 96
2025
Q1 		$4.28M Sell
5,181
-448
-8% -$373K 0.26% 93
2024
Q4 		$4.35M Buy
5,629
+761
+16% +$630K 0.23% 94
2024
Q3 		$4.31M Sell
4,868
-19
-0.4% -$17.1K 0.23% 93
2024
Q2 		$4.38M Sell
4,887
-1,652
-25% -$1.32M 0.24% 94
2024
Q1 		$3.98M Buy
6,539
+1,481
+29% +$1.05M 0.23% 101
2023
Q4 		$2.95M Buy
5,058
+1,732
+52% +$1.01M 0.18% 116
2023
Q3 		$1.79M Buy
3,326
+1,981
+147% +$1.02M 0.12% 152
2023
Q2 		$631K Buy
1,345
+235
+21% +$98.6K 0.06% 196
2023
Q1 		$381K Sell
1,110
-52
-4% -$17.5K 0.04% 215
2022
Q4 		$425K Buy
+1,162
New +$412K 0.05% 201

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bryn Mawr Capital Management's LLY Position: Q1 2026 in Review

Bryn Mawr Capital Management reduced its Eli Lilly (LLY) stake by 23% in Q1 2026, selling an estimated $1.06M and leaving 3,434 shares worth $3.16M. The position accounts for 0.15% of the portfolio, ranked #120.

Bryn Mawr Capital Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.82M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bryn Mawr Capital Management held 3,434 shares of Eli Lilly worth $3.16M as of Q1 2026.
  • Bryn Mawr Capital Management sold 1,049 Eli Lilly shares in Q1 2026, an estimated $1.06M.
  • Eli Lilly made up 0.15% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #120 holding.
  • Bryn Mawr Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Bryn Mawr Capital Management's Eli Lilly position peaked at $4.82M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.